cdmo.directory
← Compare landing

WuXi Advanced Therapies vs Aldevron

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/advancedtherapies/aldevron

CategoryWuXi Advanced TherapiesAldevron
Listed sitecdmocdmo
SummaryCell & gene therapy CDMO offering discovery, process development, analytical development, cell banking, clinical and commercial manufacturing, plus biosafety testing for biologics, mAbs, vaccines, and CGT developers.Aldevron is a CDMO specializing in mRNA manufacturing with LNP encapsulation and fill/finish, viral vector production, plasmid DNA, and gene therapy solutions from discovery through commercialization.
Services
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell-Line Development
  • Technology Transfer
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Vaccine Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • mRNA Manufacturing
  • Lipid Nanoparticle (LNP) Formulation
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Recombinant Protein Manufacturing
  • Cell-Line Development
  • Lentiviral Vector Manufacturing
  • AAV Manufacturing
  • Viral Vector Manufacturing
  • Technology Transfer
  • CMC Regulatory Submission Support
  • Cell Therapy Manufacturing
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Oncology
  • Metabolic
  • Infectious Disease
  • Rare Disease
Locations
  • Headquarters, Philadelphia, PA, United States
  • Philadelphia, Philadelphia, PA, United States
  • Allendale, Allendale, NJ, United States
  • Taufkirchen, Taufkirchen, Bavaria, Germany
  • London, London, England, United Kingdom
  • Yokohama, Yokohama, Kanagawa, Japan
  • Manufacturing & Testing, Philadelphia, PA, United States
  • Manufacturing, Allendale, NJ, United States
  • Manufacturing, Taufkirchen, Bavaria, Germany
  • Office, London, England, United Kingdom
  • Manufacturing, Yokohama, Kanagawa, Japan
  • Manufacturing & Testing, Allendale, NJ, United States
  • Manufacturing & Testing, Taufkirchen, Bavaria, Germany
  • Manufacturing & Testing, Yokohama, Kanagawa, Japan
  • Breakthrough Campus (Headquarters), Fargo, North Dakota, USA
  • Advance Campus, Fargo, North Dakota, USA
  • Innovate Campus, Madison, Wisconsin, USA
  • Discovery Center, Waltham, Massachusetts, USA
  • Headquarters
Certifications
  • FDA · Identifier: Commercial manufacturing approval
  • EMA · Identifier: Commercial manufacturing approval
  • PMDA · Identifier: Commercial manufacturing approval
  • FDA · Identifier: FDA approval for commercial manufacturing
  • EMA · Identifier: EMA approval for commercial manufacturing
  • PMDA · Identifier: PMDA approval for commercial manufacturing
  • Germany (Competent Authority) · Identifier: Certificate of GMP Compliance of a Manufacturer
  • FDA CBER · Identifier: Pre-License Inspection (PLI) and GMP audit - No Action Indicated (NAI)
  • ISO · Identifier: ISO 13485:2016
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.